Accelerate Diagnostics to Review Second Quarter 2018 Results on August 6th
19 juil. 2018 14h30 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., July 19, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Monday, August 6, 2018 to review the company’s second quarter 2018...
Accelerate Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference
05 juin 2018 11h30 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., June 05, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, President and Chief Executive Officer is scheduled to speak at the William Blair...
Accelerate Diagnostics reports Q1 2018 financial results
09 mai 2018 16h03 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., May 09, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced financial results for the quarter ending March 31, 2018. The company generated revenue of $801,000, up...
Accelerate Diagnostics to Review First Quarter 2018 Results on May 9th
30 avr. 2018 10h42 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., April 30, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 9, 2018 to review its first quarter 2018 financial...
Accelerate Diagnostics announces sizeable release of new data at ECCMID 2018
21 avr. 2018 03h37 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., April 21, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the sizeable release of new data presented by the company, its customers, and clinical experts during...
Accelerate Diagnostics, Inc. Announces Pricing of $150 Million Convertible Notes Offering
23 mars 2018 02h15 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., March 23, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (“Accelerate Diagnostics”) (NASDAQ:AXDX) today announced the pricing of $150.0 million aggregate principal amount of...
Accelerate Diagnostics Inc. Announces $150 Million Convertible Notes Offering
22 mars 2018 07h08 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., March 22, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced its intention to offer, subject to market conditions and other factors, $150.0 million...
Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017
15 févr. 2018 16h05 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary full-year 2017 financial results including the quarter ending December 31, 2017. The company...
Accelerate Diagnostics to Host Q4 and Full-Year 2017 Earnings Call on February 15, 2018
08 févr. 2018 17h25 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. will host a conference call on Thursday, February 15, 2018 to review its fourth quarter and full-year financial results...
Accelerate Diagnostics achieves CE-IVD milestone for severe bacterial pneumonia assay, doubles revenue for 2017 in Q4
10 janv. 2018 07h57 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today its declaration of conformity to the European In Vitro Diagnostic Directive 98/79/EC and CE mark of its...